-
This article originally appeared in the April 2014 issue of Neurology Alert.
-
The early ECGs are the mainstay of predicting the culprit coronary artery in ST-segment elevation myocardial infarction (STEMI)
-
Recent controversy has erupted concerning the use of prophylactic beta-blockers in patients with known or suspected coronary artery disease (CAD) undergoing non-cardiac surgery.
-
Current guidelines recommend monotherapy with either beta-blockers or rate lowering calcium blockers for heart rate control in patients with permanent atrial fibrillation (AF).
-
This was a retrospective cohort study from Quebec and Ontario, Canada, examining patients ≥ 65 years of age admitted to a hospital with a diagnosis of atrial fibrillation (AF) between 1998 and 2007.
-
Beta-blockers have long been considered a cornerstone of therapy for patients with acute myocardial infarction (MI).
-
Resistant hypertension, defined as a systolic blood pressure (BP) that remains above goal despite treatment with at least three complementary antihypertensive agents of different classes at maximally tolerated doses, has become an increasingly common diagnosis in recent years.
-
-
-
Malpractice claims involving care provided at the University of Michigan Health System in Ann Arbors three emergency departments (EDs) decreased by about half in the past decade, after a disclosure, apology, and compensation program was implemented, estimates Richard C. Boothman, JD, executive director for clinical safety and chief risk officer
